Fatigue and symptom-based clusters in post COVID-19 patients: a multicenter, prospective, observational cohort study


Merel E. B. Cornelissen, Lizan D. Bloemsma, , et. al., Journal of Translational Medicine volume 22, Article number: 191 (2024) Abstract Background In the Netherlands, the prevalence of post COVID-19 condition is estimated at 12.7% at 90–150 days…[...]

How a COVID-19 infection changes blood cells in the long run


Max-Planck-Gesellschaft Summary: New research suggests that a coronavirus infection alters the biomechanical properties of red and white blood cells, in some cases for months -- a possible explanation for long…[...]

Pathophysiological, immunological, and inflammatory features of long COVID


Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1, et. al. Front. Immunol., 27 February 2024, Volume 15 - 2024, https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality,…[...]

Large study provides scientists with deeper insight into long COVID symptoms


May 25, 2023, National Heart, Lung & Blood Institute NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics…[...]

Post-COVID-19 fatigue: A systematic review


Authors: Jian Joli1, Patrizia Buck1, Stephan Zipfel1 and Andreas Stengel1,2* Frontiers in Psychiatry Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2. This systematic review was…[...]

Long covid: Damage to multiple organs presents in young, low risk patients


Authors: Gareth Iacobucci BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4470 (Published 17 November 2020)Cite this as: BMJ 2020;371:m4470 Young, low risk patients with ongoing symptoms of covid-19 had signs of damage to multiple organs four months after initially being…[...]

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines


Authors: Johanna Chapin-Bardales, PhD, MPH1; Julianne Gee, MPH1; Tanya Myers, PhD, MSc1 In December 2020, 2 mRNA-based COVID-19 vaccines (Pfizer-BioNTech and Moderna) were granted Emergency Use Authorization by the US Food and Drug Administration as 2-dose series and…[...]